The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ.
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Editas Medicine; Guardant Health; Intellia Therapeutics; Lilly
Consulting or Advisory Role - Bristol-Myers Squibb; CG Oncology; Lucence Diagnostics; Merck; Thericon
Research Funding - CG Oncology; Predicine; Valar Labs
Travel, Accommodations, Expenses - CG Oncology; Predicine
Other Relationship - Predicine
 
Paras H Shah
No Relationships to Disclose
 
Tyler F. Stewart
Consulting or Advisory Role - AstraZeneca; Seattle Genetics/Astellas
Research Funding - GRAIL
 
Trinity Bivalacqua
Honoraria - Ferring; Janssen; UROGENE
 
Donald L. Lamm
Consulting or Advisory Role - 1
Research Funding - CG Oncology (Inst)
 
Daniel M. Geynisman
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Joshua J Meeks
Honoraria - Astellas Pharma; AstraZeneca; Imvax; incyte; Janssen; Merck; Pfizer; Prokarium; Urogen pharma
Research Funding - Epizyme; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Edward M. Uchio
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; CG Oncology; Dendreon; Janssen Oncology; Merck; Pfizer; Seagen
(OPTIONAL) Uncompensated Relationships - Astellas Pharma; AstraZeneca; Bayer; Genomic Health; Janssen Oncology; Lantheus Medical Imaging; Merck; Myriad Genetics; Pfizer
 
Joseph M Jacob
Consulting or Advisory Role - Janssen; Photocure
Speakers' Bureau - Urogen pharma
 
Rian J. Dickstein
No Relationships to Disclose
 
Shane Pearce
No Relationships to Disclose
 
James M. Burke
Employment - CG Oncology
Leadership - CG Oncology
Stock and Other Ownership Interests - CG Oncology
Consulting or Advisory Role - CG Oncology; Kalivir Immunotherapeutics
Travel, Accommodations, Expenses - CG Oncology; Kalivir Immunotherapeutics
 
Gary D. Steinberg
Stock and Other Ownership Interests - CG Oncology; enGene; Epivax Therapeutics
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Asieris Pharmaceuticals; AstraZeneca; Aura Biosciences; Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; Imvax; MDxHealth; Merck; NanOlogy; Natera; Nonagen Bioscience; photocure; Roche/Genentech; Taris BioMedical; Verity Pharmaceuticals